Drug intelligence / Profile preview

PJ003

Development stage
Unknown
Lead developer
Chongqing Peg-Bio Biopharm
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

PJ003 (also known as HZBio1) is a PEGylated recombinant urate oxidase (uricase) being developed by Chongqing Peg-Bio Biopharm and Hangzhou Grand Biologic Pharmaceutical for the treatment of gout and hyperuricemia. Humans lack a functional uricase enzyme, which normally catalyzes the conversion of poorly soluble uric acid into the more soluble and easily excreted metabolite allantoin. By supplying exogenous PEGylated uricase, PJ003 rapidly reduces serum uric acid levels and promotes the dissolution of monosodium urate crystal deposits in joints and tissues. The PEGylation of the recombinant enzyme is designed to extend its half-life and reduce immunogenicity, addressing common limitations of non-PEGylated uricase therapies. PJ003 is currently in Phase 2/3 clinical development in China.

Other names
PEGylated urate oxidasePEGylated uricasepegylated recombinant uricaserecombinant urate oxidase

Beyond the preview

Go deeper on PJ003.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PJ003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call